According to the report by Reuters, the University of Oxford has launched the study to assess the safety and immunogenicity of the COVID-19 vaccine in children for the first time from a vaccine developed by AstraZeneca.
The age group will be 6 and 17 to determine the effectiveness of vaccine.Around 300 volunteers will be inoculated this month.
